menu search

Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data

November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Aligos Therapeu...

November 3, 2023, 8:30 pm

Pantheon vision raises $2.5 million in seed funding to launch development of bioengineered corneal implant

The medical device startup is focused on addressing significant unmet needs of patients suffering from ...

November 2, 2023, 6:06 pm

Vincerx pharma to present three posters at ash 2023 in december

VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...

November 2, 2023, 9:10 am

Tarsus to report third quarter 2023 financial results on thursday, november 9, 2023

IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on ...

November 1, 2023, 10:35 pm

Tarsus to report third quarter 2023 financial results on thursday, november 9, 2023

IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on ...

November 1, 2023, 6:35 pm

Mersana therapeutics to host third quarter 2023 conference call on november 7, 2023

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on d...

October 31, 2023, 4:30 pm

Yen feels the heat as boj’s yield cap redefinition underwhelms

Japanese Yen is facing renewed pressure following BoJ’s policy announcement, where expectations for significant changes were left largely ...

October 31, 2023, 4:49 am

Eton pharmaceuticals to report third quarter 2023 financial results on thursday, november 9, 2023

DEER PARK, Ill., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developi...

October 30, 2023, 6:50 am

Acceptance of polyamine inhibitor car-t combination abstract for online publication

MINNEAPOLIS, Oct. 25, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics...

October 25, 2023, 12:15 pm

Medivir to report new and updated data from ongoing phase 2a hcc study as part of its q3 report on friday

Webcasted Conference Call on Friday, October 27, 2023 at 14.00 CET STOCKHOLM , Oct. 25, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a ph...

October 25, 2023, 2:46 am

Panbela to host third quarter 2023 earnings conference call on november 9, 2023

MINNEAPOLIS, Oct. 24, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics...

October 24, 2023, 12:15 pm

Panbela to host third quarter 2023 earnings conference call on november 9, 2023

MINNEAPOLIS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeuti...

October 24, 2023, 8:15 am

Ardelyx shares positive data on symptom response during treatment with ibsrela® (tenapanor) for ibs-c and hosts ibs-c product theater at acg 2023

WALTHAM, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, devel...

October 23, 2023, 12:07 pm

Ardelyx to report third quarter 2023 financial results on october 31, 2023

WALTHAM, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo...

October 18, 2023, 4:02 pm

Ardelyx announces amendment of debt financing agreement with slr capital partners to provide $50 million of additional committed capital

Additional non-dilutive capital extends runway to support the launch of XPHOZAH® (tenapanor) and continued commercial investment into IBSRELA® (tena...

October 17, 2023, 11:23 pm

Merck to present latest research from oncology portfolio at esmo 2023

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced that 28 abstracts featuring the latest research ...

October 16, 2023, 2:00 am

Ardelyx to present data updates for xphozah (tenapanor) for hyperphosphatemia at kidney week 2023 november 1-5 in philadelphia, pa

WALTHAM, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develo...

October 13, 2023, 8:00 am

An2 therapeutics to present new data for epetraborole at idweek 2023

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatment...

October 11, 2023, 12:01 am

Rising sun over ardelyx: a tenapanor tale (rating upgrade)

Ardelyx shows strong financial health, underpinned by 61% QoQ growth in flagship product Ibsrela and an 18-month cash runway. Japanese approval of ten...

October 9, 2023, 8:55 am

Okyo pharma files ind application ok-101 to treat neuropathic corneal pain

OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer noted, told investors it has filed an Investigational New Drug (IND) application wit...

October 9, 2023, 8:20 am


Search within

Pages Search Results: